BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 34622798)

  • 21. Natural IgM is produced by CD5- plasma cells that occupy a distinct survival niche in bone marrow.
    Reynolds AE; Kuraoka M; Kelsoe G
    J Immunol; 2015 Jan; 194(1):231-42. PubMed ID: 25429072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exome sequencing reveals RAG1 mutations in a child with autoimmunity and sterile chronic multifocal osteomyelitis evolving into disseminated granulomatous disease.
    Reiff A; Bassuk AG; Church JA; Campbell E; Bing X; Ferguson PJ
    J Clin Immunol; 2013 Nov; 33(8):1289-92. PubMed ID: 24122031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual-reactive B cells are autoreactive and highly enriched in the plasmablast and memory B cell subsets of autoimmune mice.
    Fournier EM; Velez MG; Leahy K; Swanson CL; Rubtsov AV; Torres RM; Pelanda R
    J Exp Med; 2012 Sep; 209(10):1797-812. PubMed ID: 22927551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Defective B-cell memory in patients with Down syndrome.
    Verstegen RHJ; Driessen GJ; Bartol SJW; van Noesel CJM; Boon L; van der Burg M; van Dongen JJM; de Vries E; van Zelm MC
    J Allergy Clin Immunol; 2014 Dec; 134(6):1346-1353.e9. PubMed ID: 25159464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TLR7- and TLR9-responsive human B cells share phenotypic and genetic characteristics.
    Simchoni N; Cunningham-Rundles C
    J Immunol; 2015 Apr; 194(7):3035-44. PubMed ID: 25740945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Class Switch Recombination Defects: impact on B cell maturation and antibody responses.
    Renner ED; Krätz CE; Orange JS; Hagl B; Rylaarsdam S; Notheis G; Durandy A; Torgerson TR; Ochs HD
    Clin Immunol; 2021 Jan; 222():108638. PubMed ID: 33276124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exclusion of natural autoantibody-producing B cells from IgG memory B cell compartment during T cell-dependent immune responses.
    Matejuk A; Beardall M; Xu Y; Tian Q; Phillips D; Alabyev B; Mannoor K; Chen C
    J Immunol; 2009 Jun; 182(12):7634-43. PubMed ID: 19494287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Manifestations, Mutational Analysis, and Immunological Phenotype in Patients with RAG1/2 Mutations: First Cases Series from Mexico and Description of Two Novel Mutations.
    Lugo-Reyes SO; Pastor N; González-Serrano E; Yamazaki-Nakashimada MA; Scheffler-Mendoza S; Berron-Ruiz L; Wakida G; Nuñez-Nuñez ME; Macias-Robles AP; Staines-Boone AT; Venegas-Montoya E; Alaez-Verson C; Molina-Garay C; Flores-Lagunes LL; Carrillo-Sanchez K; Niemela J; Rosenzweig SD; Gaytan P; Yañez JA; Martinez-Duncker I; Notarangelo LD; Espinosa-Padilla S; Cruz-Munoz ME
    J Clin Immunol; 2021 Aug; 41(6):1291-1302. PubMed ID: 33954879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TLR9 signalling in HCV-associated atypical memory B cells triggers Th1 and rheumatoid factor autoantibody responses.
    Comarmond C; Lorin V; Marques C; Maciejewski-Duval A; Joher N; Planchais C; Touzot M; Biard L; Hieu T; Quiniou V; Desbois AC; Rosenzwajg M; Klatzmann D; Cacoub P; Mouquet H; Saadoun D
    J Hepatol; 2019 Nov; 71(5):908-919. PubMed ID: 31279905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RAG1 deficiency with a shifting B cell phenotype and chromosomal instability.
    Ghosh S; Hönscheid A; Schwarz K; Eirich K; Schindler D; Schönberger S; Speckmann C; Borkhardt A; Laws HJ
    Clin Immunol; 2014; 152(1-2):65-7. PubMed ID: 24583411
    [No Abstract]   [Full Text] [Related]  

  • 31. Delineating Human B Cell Precursor Development With Genetically Identified PID Cases as a Model.
    Wentink MWJ; Kalina T; Perez-Andres M; Del Pino Molina L; IJspeert H; Kavelaars FG; Lankester AC; Lecrevisse Q; van Dongen JJM; Orfao A; van der Burg M
    Front Immunol; 2019; 10():2680. PubMed ID: 31849931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. B cell specific natural IgM autoantibodies: multifunctional regulators of the humoral immune response (a review).
    Uher F; Kiss K; Rácz J; Mihalik R; Puskás E; Alonso ME
    Acta Microbiol Immunol Hung; 1995; 42(1):3-17. PubMed ID: 7620810
    [No Abstract]   [Full Text] [Related]  

  • 33. Lymphoma Driver Mutations in the Pathogenic Evolution of an Iconic Human Autoantibody.
    Singh M; Jackson KJL; Wang JJ; Schofield P; Field MA; Koppstein D; Peters TJ; Burnett DL; Rizzetto S; Nevoltris D; Masle-Farquhar E; Faulks ML; Russell A; Gokal D; Hanioka A; Horikawa K; Colella AD; Chataway TK; Blackburn J; Mercer TR; Langley DB; Goodall DM; Jefferis R; Gangadharan Komala M; Kelleher AD; Suan D; Rischmueller M; Christ D; Brink R; Luciani F; Gordon TP; Goodnow CC; Reed JH
    Cell; 2020 Mar; 180(5):878-894.e19. PubMed ID: 32059783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A single autosomal gene defect severely limits IgG but not IgM responses in B lymphocyte-deficient A/WySnJ mice.
    Miller DJ; Hanson KD; Carman JA; Hayes CE
    Eur J Immunol; 1992 Feb; 22(2):373-9. PubMed ID: 1531637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoimmunity and immunodeficiency disease.
    Rosen FS
    Ciba Found Symp; 1987; 129():135-48. PubMed ID: 3315500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Precursor B-cell development in bone marrow of Good syndrome patients.
    Del Pino Molina L; Wentink M; van Deuren M; van Hagen PM; Smith CIE; van der Burg M
    Clin Immunol; 2019 Mar; 200():39-42. PubMed ID: 30690192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Redemption of autoantibodies on anergic B cells by variable-region glycosylation and mutation away from self-reactivity.
    Sabouri Z; Schofield P; Horikawa K; Spierings E; Kipling D; Randall KL; Langley D; Roome B; Vazquez-Lombardi R; Rouet R; Hermes J; Chan TD; Brink R; Dunn-Walters DK; Christ D; Goodnow CC
    Proc Natl Acad Sci U S A; 2014 Jun; 111(25):E2567-75. PubMed ID: 24821781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IgM and IgD B cell receptors differentially respond to endogenous antigens and control B cell fate.
    Noviski M; Mueller JL; Satterthwaite A; Garrett-Sinha LA; Brombacher F; Zikherman J
    Elife; 2018 Mar; 7():. PubMed ID: 29521626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoimmunity and Immunodeficiency.
    Dosanjh A
    Pediatr Rev; 2015 Nov; 36(11):489-94; quiz 495. PubMed ID: 26527628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eleven percent intact PGM3 in a severely immunodeficient patient with a novel splice-site mutation, a case report.
    Lundin KE; Wang Q; Hamasy A; Marits P; Uzunel M; Wirta V; Wikström AC; Fasth A; Ekwall O; Smith CIE
    BMC Pediatr; 2018 Aug; 18(1):285. PubMed ID: 30157810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.